An official website of the United States government
09/27/2022: Lab Advisory: FDA Updates COVID-19 Test Policy and FAQs
Audience: Laboratory and Testing Professionals
Level: Laboratory Advisory
On September 27, 2022, the U.S. Food and Drug Administration (FDA) updated its COVID-19 test policy to address public health testing needs during this phase of the COVID-19 public health emergency. The FDA is revising its COVID-19 test policy to encourage most COVID-19 test developers to pursue a traditional premarket review pathway for their tests rather than emergency use authorization.
Please review the revised Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency and updated FAQs on Testing for SARS-CoV-2 and share this message with your networks.
Opt in to receive updates from the CDC Laboratory Outreach Communication System (LOCS).
Resources
Questions?
- If you are a clinical or public health laboratory professional, contact LOCS.
- For media inquiries, contact the CDC Newsroom.
- For all other questions, contact CDC-INFO.
Thank you,
The Laboratory Outreach Communication System
Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS)
Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)
Centers for Disease Control and Prevention (CDC)